SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950131-00-001098
Filing Date
2000-02-11
Accepted
2000-02-11 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 NPS PHARMACEUTICALS, INC. SC 13G 11160
  Complete submission text file 0000950131-00-001098.txt   13164
Mailing Address
Business Address 420 CHIPETA WAY SUITE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Subject) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-44877 | Film No.: 535879
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 227 W MONROE ST STE 3000 CHICAGO IL 60606
Business Address 227 W MONROE STREET SUITE 3000 CHICAGO IL 60606 3126349230
WANGER ASSET MANAGEMENT LP (Filed by) CIK: 0000908733 (see all company filings)

IRS No.: 363820584 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 0000